Antibody to genetic products differentially expressed in tumors and the use thereof

US9775785B2 · kind B2 · utility

Assignee

• Ganymed Pharmaceuticals GmbH · DE

Inventors

• Ozlem Tureci · Homburg, DE
• Ugur Sahin · Mainz, DE
• Michael Koslowski · Mainz, DE
• Stephan Fritz · Flonheim, DE
• Harald-Gerhard Geppert · Hannover, DE

Key dates

• Filing date: Apr 1, 2015
• Grant date: Oct 3, 2017
• Expiry date: Apr 1, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/75
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

According to the invention, gene products expressed in a tumor-associated manner and the nucleic acids coding therefor were identified. The invention relates to the therapy and diagnosis of diseases wherein said gene products expressed in a tumor-associated manner are aberrantly expressed. The invention also relates to proteins, polypeptides and peptides which are expressed in a tumor associated manner and to nucleic acids coding therefor.